Kralj, S.; Jukič, M.; Bahun, M.; Kranjc, L.; Kolarič, A.; Hodošček, M.; Ulrih, N.P.; Bren, U.
Identification of Triazolopyrimidinyl Scaffold SARS-CoV-2 Papain-Like Protease (PLpro) Inhibitor. Pharmaceutics 2024, 16, 169.
https://doi.org/10.3390/pharmaceutics16020169
AMA Style
Kralj S, Jukič M, Bahun M, Kranjc L, Kolarič A, Hodošček M, Ulrih NP, Bren U.
Identification of Triazolopyrimidinyl Scaffold SARS-CoV-2 Papain-Like Protease (PLpro) Inhibitor. Pharmaceutics. 2024; 16(2):169.
https://doi.org/10.3390/pharmaceutics16020169
Chicago/Turabian Style
Kralj, Sebastjan, Marko Jukič, Miha Bahun, Luka Kranjc, Anja Kolarič, Milan Hodošček, Nataša Poklar Ulrih, and Urban Bren.
2024. "Identification of Triazolopyrimidinyl Scaffold SARS-CoV-2 Papain-Like Protease (PLpro) Inhibitor" Pharmaceutics 16, no. 2: 169.
https://doi.org/10.3390/pharmaceutics16020169
APA Style
Kralj, S., Jukič, M., Bahun, M., Kranjc, L., Kolarič, A., Hodošček, M., Ulrih, N. P., & Bren, U.
(2024). Identification of Triazolopyrimidinyl Scaffold SARS-CoV-2 Papain-Like Protease (PLpro) Inhibitor. Pharmaceutics, 16(2), 169.
https://doi.org/10.3390/pharmaceutics16020169